These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7426004)

  • 21. Effects of angiotensin infusion on renal function in the unanesthetized rat.
    Malvin RL; Vander AJ
    Am J Physiol; 1967 Nov; 213(5):1205-8. PubMed ID: 4293369
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
    Grove L; Christensen P; Bie P
    Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular and tubular effects of arginine vasotocin in water snakes (Natrix sipedon).
    Dantzler WH
    Am J Physiol; 1967 Jan; 212(1):83-91. PubMed ID: 6016018
    [No Abstract]   [Full Text] [Related]  

  • 24. Arginine vasopressin potentiates natriuretic effect of atrial peptide.
    Graczak LM; Nicolodi LK; Hartupee DA; Blaine EH
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H925-7. PubMed ID: 2522287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on the mechanism of vasopressin escape: effects of chronic vasopressin and overhydration on renal tissue osmolality and electrolytes in dogs.
    Chan WY
    J Pharmacol Exp Ther; 1973 Jan; 184(1):244-51. PubMed ID: 4686011
    [No Abstract]   [Full Text] [Related]  

  • 26. Intrathecal vasopressin administration alters efferent renal nerve activity.
    Riphagen CL; Pittman QJ
    Proc West Pharmacol Soc; 1987; 30():175-7. PubMed ID: 3628272
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of prolonged administration of vasopressin on plasma sodium and on renal excretion of electrolytes and water.
    Chan WY
    J Pharmacol Exp Ther; 1971 Jul; 178(1):141-51. PubMed ID: 5087392
    [No Abstract]   [Full Text] [Related]  

  • 28. [HYPONATREMIA WITH NATRIURESIS CONSERVED DUE TO DISORDER OF ELIMINATION OF FREE WATER IN THE COURSE OF A GUILLAIN-BARRE SYNDROME].
    POYART C; POCIDALO JJ
    Rev Fr Etud Clin Biol; 1964 Dec; 9():1068-71. PubMed ID: 14251627
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.
    Bragadottir G; Redfors B; Nygren A; Sellgren J; Ricksten SE
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1052-9. PubMed ID: 19572935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of infusion of pharmacologic amounts of vasopressin on renal electrolyte excretion.
    Kurtzman NA; Rogers PW; Boonjarern S; Arruda JA
    Am J Physiol; 1975 Mar; 228(3):890-4. PubMed ID: 234693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activities of arginine-vasopressin analogues designed from a conformation-activity approach.
    Botos CR; Smith CW; Chan YL; Walter R
    J Med Chem; 1979 Aug; 22(8):926-31. PubMed ID: 490538
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
    Ledderhos C; Mattson DL; Skelton MM; Cowley AW
    Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of theophylline on the kidney].
    Vlasov VV
    Farmakol Toksikol; 1970; 33(6):697-9. PubMed ID: 5518490
    [No Abstract]   [Full Text] [Related]  

  • 34. Diazoxide and renal function in man.
    Johnson BF
    Clin Pharmacol Ther; 1971; 12(5):815-24. PubMed ID: 4936146
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of verapamil on different parameters of renal function].
    MacLaughlin M; Aires MM; Malnic G
    Arq Bras Cardiol; 1979 May; 32(5):335-42. PubMed ID: 518380
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of V1/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs.
    Rose CE; Rose KY; Kinter LB
    Am J Physiol; 1991 Feb; 260(2 Pt 2):F273-82. PubMed ID: 1825453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel selective hypotensive vasopressin peptides. A new vasodilating vasopressin receptor?
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Adv Exp Med Biol; 1998; 449():451-3. PubMed ID: 10026838
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
    Ganger DR; Gottstein J; Blei AT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of a blood circulation analeptic amino-alkyl-theophylline (Akrimor) on kidney function and renal electrolyte balance].
    Bihler K; Birtel FJ; Gundlach G
    Anaesthesist; 1972 Oct; 21(10):428-36. PubMed ID: 4639237
    [No Abstract]   [Full Text] [Related]  

  • 40. [Electrolyte excretion and renal concentrating ability after inhibition of prostaglandin synthesis with indomethacin. Studies in healthy subjects and in patients with hereditary central diabetes insipidus].
    Maschler CL; Düsing R; Kramer HJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1327-31. PubMed ID: 611846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.